It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Photoplethysmography (PPG) measured by smartphone has the potential for a large scale, non-invasive, and easy-to-use screening tool. Vascular aging is linked to increased arterial stiffness, which can be measured by PPG. We investigate the feasibility of using PPG to predict healthy vascular aging (HVA) based on two approaches: machine learning (ML) and deep learning (DL). We performed data preprocessing, including detrending, demodulating, and denoising on the raw PPG signals. For ML, ridge penalized regression has been applied to 38 features extracted from PPG, whereas for DL several convolutional neural networks (CNNs) have been applied to the whole PPG signals as input. The analysis has been conducted using the crowd-sourced Heart for Heart data. The prediction performance of ML using two features (AUC of 94.7%) – the a wave of the second derivative PPG and tpr, including four covariates, sex, height, weight, and smoking – was similar to that of the best performing CNN, 12-layer ResNet (AUC of 95.3%). Without having the heavy computational cost of DL, ML might be advantageous in finding potential biomarkers for HVA prediction. The whole workflow of the procedure is clearly described, and open software has been made available to facilitate replication of the results.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Bologna, Department of Physics and Astronomy, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)
2 University of Bologna, Department of Specialised, Diagnostic and Experimental Medicine, Bologna, Italy (GRID:grid.6292.f) (ISNI:0000 0004 1757 1758)
3 Happitech, Amsterdam, The Netherlands (GRID:grid.6292.f)
4 University Medical Center Utrecht, Department of Cardiology, Division Heart & Lungs, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352); University College London, Institute of Cardiovascular Science, Faculty of Population Health Sciences, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Health Data Research UK and Institute of Health Informatics, University College London, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
5 University Medical Center Utrecht, Department of Biostatistics and Research Support, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352)